First, Octave presented insights on the company’s first of its kind, MS-specific multivariate biomarker assay panel and leveraging deep scan proteomics in multiple posters at ACTRIMS Forum 2023.

In addition, Octave presented insights on the company’s multivariate biomarker blood test, the first of its kind and designed specifically for MS, in multiple posters at ECTRIMS 2022.